Rivanna Accuro 3D Ultrasound Device for Obesity

The University of Texas Medical Branch, Galveston, TX
Obesity+2 More ConditionsRivanna Accuro 3D Ultrasound Device - Device
Eligibility
18 - 50
Female
What conditions do you have?
Select

Study Summary

This trial will compare two methods of giving epidural pain relief during childbirth.

Eligible Conditions
  • Morbid Obesity
  • Pain
  • Pregnancy

Treatment Effectiveness

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: Within first 90 minutes following catheter placement

Day 3
Pressure pain thresholds and pain scores
Beginning of needle insertion till catheter placement-15 minutes
Needle depth
Number of needle insertion attempts and redirections
Procedural difficulty
Day 30
Complications
Within first 90 minutes following catheter placement
Successful epidural catheter placement

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Palpation
1 of 2
Rivanna Accuro 3D Ultrasound Device
1 of 2

Active Control

Experimental Treatment

308 Total Participants · 2 Treatment Groups

Primary Treatment: Rivanna Accuro 3D Ultrasound Device · No Placebo Group · N/A

Rivanna Accuro 3D Ultrasound Device
Device
Experimental Group · 1 Intervention: Rivanna Accuro 3D Ultrasound Device · Intervention Types: Device
Palpation
Other
ActiveComparator Group · 1 Intervention: Palpation · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within first 90 minutes following catheter placement

Who is running the clinical trial?

The University of Texas Medical Branch, GalvestonLead Sponsor
228 Previous Clinical Trials
54,674 Total Patients Enrolled
10 Trials studying Obesity
320 Patients Enrolled for Obesity
Rovnat Babazade, MDPrincipal InvestigatorThe University of Texas Medical Branch

Eligibility Criteria

Age 18 - 50 · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You plan to have pain relief medication (epidural) during vaginal delivery.

Frequently Asked Questions

Are participants under the age of fifty eligible for this clinical experiment?

"The eligible patient cohort for this clinical trial spans between 18 to 50 years of age." - Anonymous Online Contributor

Unverified Answer

What is the current enrollment figure of this trial?

"Affirmative. Information from clinicaltrials.gov makes it clear that this study is currently recruiting, with the original post date of February 20th 2018 and most recent update on January 3rd 2022. The investigation desires to enlist 308 volunteers across a single location." - Anonymous Online Contributor

Unverified Answer

Is enrollment in this experiment currently open?

"The clinicaltrials.gov registry indicates that this medical study is presently seeking participants; it was first posted on February 20th 2018 and the most recent revisions were made January 3rd 2022." - Anonymous Online Contributor

Unverified Answer

Is there room for me in this research endeavor?

"The trial is currently seeking 308 individuals, aged 18 to 50 years old, who are suffering from pain and have BMI values of 40 or higher. Furthermore, pregnant patients can also be considered for the study." - Anonymous Online Contributor

Unverified Answer

What are the main objectives of this research endeavor?

"The primary goal of this clinical trial, to be measured over a 90 minute period following catheter placement, is the count of insertion attempts and redirections. Subsequently, procedural difficulty will be rated using a 10-point Likert scale, complications related to the epidural will be noted down, as well as needle depth from skin and measured depth via ultrasound." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.